Skip to main content

Table 5 Effects of Spirulina platensis powder followed by cyclophosphamide administration on bone marrow cells

From: Evaluation of the protective effects of Spirulina platensis against cyclophosphamide-induced genotoxicity

Mice

Normal Control

Positive Control

SP 37.5 + C

SP 75 + C

SP 150 + C

MnPCEs/5000 PCEs

PCEs%

MnPCEs/5000 PCEs

PCEs%

MnPCEs/5000 PCEs

PCEs%

MnPCEs/5000 PCEs

PCEs%

MnPCEs/5000 PCEs

PCEs%

1

5

51.64

17

43.14

13

44.72

8

43.73

5

41.87

2

6

46.42

9

43.08

15

46.80

6

45.96

6

45.94

3

5

56.61

17

39.77

15

42.47

10

45.52

6

45.08

4

5

46.43

19

41.77

14

44.93

6

42.24

7

42.42

5

4

41.04

15

44.43

9

47.39

5

45.03

5

45.63

M ± SEM

5.00 ± 0.32

48.43 ± 3.10

15.40 ± 1.72####

42.44 ± 0.79#

13.22 ± 1.11

45.26 ± 0.87

7.00 ± 0.89***

44.50 ± 1.41

5.80 ± 0.37****

44.19 ± 0.85

  1. Five batches of 5 mice were formed. The normal control was treated with distilled water; the positive control was given cyclophosphamide at 100 mg/kg; SP 37.5 + C; SP 75 + C; and SP 150 + C were pretreated with total extract at doses of 37.5, 75, and 150 mg/kg and subsequently given cyclophosphamide at 100 mg/kg. # p < 0.05 # # # # p < 0.0001 (compared to the normal control); ***p < 0.001 ****p < 0.0001 (compared to the positive control)
  2. PCE = micronucleus in polychromatic erythrocytes; PCE = polychromatic erythrocytes; NCE = normochromatic erythrocytes